← Leaderboards
Zuoming Sun
University Of Illinois At Chicago
$10,769,004
Attributed
$10,769,004
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $835K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,769,004 · 4
By mechanism
R01$9,870,004 · 2
R21$484,000 · 1
R56$415,000 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Illinois At Chicago
Same institution · by research overlap
- Nissim Hay$25,480,567
- Ah-Ng Tony Kong$19,827,201
- Andrei V Gudkov$19,460,065
- Hiroaki Kiyokawa$7,592,989
- Janai R. Carr-Ascher$139,152
Others in their field
Top investigators on “T-Lymphocyte”
- Barton F Haynes · Duke University$296,833,570
- Lawrence Corey · Fred Hutchinson Cancer Center$270,341,865
- Dan H. Barouch · Fred Hutchinson Cancer Center$117,305,894
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$107,651,960
- Alessandro Sette · La Jolla Institute For Immunology$75,756,097
- Rama Rao Amara · Emory University$69,530,112
Research focus
T-LymphocyteMediatingIn VivoCellsInnovationCollaborationsImmune ResponseAutoimmunityImmune SystemMultiple SclerosisAutoimmune DiseasesPreventRegulationGenerationsTranscription FactorExperimental Autoimmune EncephalomyelitisImmunityCell PhysiologyPathogenThymocyteThymocyte DevelopmentInterleukin-17Clinical ApplicationInhibitor/Antagonist
Grant awards (25)
Cbfb in RORgt-regulated T cell function$726,464
R01 · FY2025 · AI · contact PI
Cbfb in RORgt-regulated T cell function$753,164
R01 · FY2024 · AI · contact PI
Steroid nuclear receptor coactivators in T cell differentiation$510,194
R01 · FY2023 · AI · contact PI
Steroid nuclear receptor coactivators in T cell differentiation$510,194
R01 · FY2022 · AI · contact PI
Function of TCF-1 in antagonizing malignancy$264,000
R21 · FY2022 · AI · contact PI
Steroid nuclear receptor coactivators in T cell differentiation$510,194
R01 · FY2021 · AI · contact PI
Function of TCF-1 in antagonizing malignancy$220,000
R21 · FY2021 · AI · contact PI
Steroid nuclear receptor coactivators in T cell differentiation$510,194
R01 · FY2020 · AI · contact PI
Steroid nuclear receptor coactivators in T cell differentiation$510,194
R01 · FY2019 · AI · contact PI
Differential mechanisms for RORgammat-regulated thymocyte development and Th17 di$420,000
R01 · FY2018 · AI · contact PI
Differential mechanisms for RORgammat-regulated thymocyte development and Th17 di$420,000
R01 · FY2017 · AI · contact PI
Differential mechanisms for RORgammat-regulated thymocyte development and Th17 di$420,000
R01 · FY2016 · AI · contact PI
Differential mechanisms for RORgammat-regulated thymocyte development and Th17 di$420,000
R01 · FY2015 · AI · contact PI
PKC-theta function in RORgammat-regulated Th17 differentiation$415,000
R01 · FY2015 · AI · contact PI
Differential mechanisms for RORgammat-regulated thymocyte development and Th17 di$420,000
R01 · FY2014 · AI · contact PI
PKC-theta function in RORgammat-regulated Th17 differentiation$415,000
R01 · FY2014 · AI · contact PI
PKC-theta function in RORgammat-regulated Th17 differentiation$390,100
R01 · FY2013 · AI · contact PI
PKC-theta function in RORgammat-regulated Th17 differentiation$415,000
R01 · FY2012 · AI · contact PI
PKC-theta function in RORgammat-regulated Th17 differentiation$415,000
R01 · FY2011 · AI · contact PI
Dissecting PKC-theta-regulated T cell functions in allograft rejection$415,000
R56 · FY2010 · AI · contact PI
In vivo Analysis of RORgamma mediated Functions$343,093
R01 · FY2008 · AI · contact PI
In vivo Analysis of RORgamma mediated Functions$326,434
R01 · FY2007 · AI · contact PI
In vivo Analysis of RORgamma mediated Functions$336,183
R01 · FY2006 · AI · contact PI
In vivo Analysis of RORgamma mediated Functions$344,273
R01 · FY2005 · AI
In vivo Analysis of RORgamma mediated Functions$339,323
R01 · FY2004 · AI